October 24

John Bode Obtains Reversal on Fees from FDA

FDA announced today, “FDA does not intend to issue invoices for reinspection or recall order fees until this guidance (on reducing burden on small business) document has been published” and “FDA is not in a position to assess import reinspection fees until the agency has resolved these issues and the agency notifies the public.” John.